Owkin, Boehringer Ingelheim ink AI drug discovery deal - PharmaLive

A biotech company is using AI with a major pharmaceutical firm to discover new drugs faster. This could eventually lead to better medicines reaching patients quicker, making it relevant to anyone concerned about healthcare innovation.